Comparative efficacy and safety of first-line therapies for advanced HER2-negative gastric or gastroesophageal junction adenocarcinoma: A systematic review and network meta-analysis

Critical Reviews in Oncology/Hematology · Elsevier

Аннотация

Publication date: December 2026 Source: Critical Reviews in Oncology/Hematology, Volume 228 Author(s): Wenwei Yang, Qi Cao, Biyang Cao, Jingyu Lu, Letian Zhang, Demei Feng, Lin Yang

Читать у издателя →

Похожие статьи